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Poverty is the ultimate form of pollution in a world out of balance
with people's needs and its own future.
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Fear of Phenolphthalein?
In December scientists announced that
phenolphthalein, a substance used for
almost a century in over-the-counter laxa-
tives, showed clear evidence of carcino-
genicity in rodent studies and may present
a risk to humans, particularly individuals
who ingest amounts greatly exceeding rec-
ommended doses.
The determination was made by the
National Toxicology Program, which initi-
ated toxicology and carcinogenicity studies
of phenolphthalein because no long-term
animal studies were available to allow eval-
uation of the potential risks to humans
from prolonged use of the drug. The
National Cancer Institute had nominated
phenolphthalein for study.
In the NTP studies, rats and mice were
fed phenolphthalein over a period of two
years at doses of 12,000, 25,000, and
50,000 parts per million (ppm) to rats and
3,000, 6,000, and 12,000 ppm to mice.
The rodents were then examined for the
presence of cancerous and noncancerous
pathology. The study results are summa-
rized as follows:
* dear evidence ofcarcinogenic activity in
male F344/N rats based on markedly
increased incidences ofbenign neoplasms
of the adrenal medulla and benign and
malignant neoplasms ofthe kidneys;
* some evidence ofcarcinogenic activity in
female rats based on increased incidences of
benign pheochromocytoma in the 12,000
ppm dose group, and ofbenign or malig-
nantneoplasms oftheadrenal medulla;
* dear evidence ofcarcinogenic activity in
male mice based on histiocytic sarcoma
and malignant lymphoma;
* clear evidence of carcinogenic activity in
female micebased on increased incidences
of histiocytic sarcoma, malignant lym-
phoma ofall types, lymphoma ofthymic
origin, and benign ovarian tumors.
According to the NTP, phenolph-
thalein may cause cellular alterations in
animals by a number of mechanisms
including chromosomal damage, and
through estrogenlike activity. Additional
studies are underway to further understand
the mechanisms by which phenolphthalein
acts. The NTP technical report on phe-
nolphthalein stresses, however, that it is
difficult to extrapolate human risk from
animal studies, and no population studies
of phenolphthalein users have shown an
increased risk for disease. This does not
mean, however, that the drug is necessarily
risk-free for humans. George Lucier, direc-
tor of the Environmental Toxicology
Program at the NIEHS, says, "Although
Unwanted ingredient? New research shows phenolphthalein, a drug found in many laxatives, may
have carcinogenic side effects in animals.
we can't precisely determine the relevance
of the NTP animal findings for human
risk, theydo provide a red flag ofcaution."
Alternatives in Animal Testing
The three "R's" of animal testing are
refine, reduce, and replace. Respectively,
they denote modifying toxicological test
procedures to lessen or eliminate animals'
pain, curtailing the number of animals
required for a test, and substituting test
animals with non-animal methods or phy-
logenetically lower species. Total replace-
ment would mean eliminating the use of
animals by using microbes, cells, tissues,
and other in vitro methods, as well as using
computerized information databases and
mathematical models.
Applying the three Rs to the develop-
ment and validation ofnew and improved
testing methods is mandated by Section
1301 of the National Institutes of Health
Revitalization Act of 1993 (PL 103-43).
The Interagency Coordinating Committee
on the Validation ofAlternative Methods
(ICCVAM) was established at the NIEHS
in 1994 to fulfill this mandate byestablish-
ing criteria for the validation ofalternative
testing methods, and recommending
processes by which they can be accepted
for regulatory use.
This daunting task was discussed at the
National Toxicology Program Workshop
onValidation and RegulatoryAcceptance of
Alternative Toxicological Test Methods,
held in Arlington, Virginia, 11-12
December 1995. The workshop was orga-
nizedbyICCVAM, which consists ofadhoc
representatives of 15 federal scientific and
regulatory agencies. The purpose of the
public workshop was to obtain comments
and recommendations from experts and
interested stakeholders from industry, acad-
emia, government, public interest groups,
and animal welfare organizations on a draft
reportpreparedbythe committee. Thedraft
report and workshop report was presented
at an Organization for Economic Cooper-
ation and Development (OECD) workshop
on toxicological test alternatives held in
January 1996 in Stockholm, Sweden. Neil
Wilcox, special assistant to the associate
commissioner oftheFDA, said, "The forum
successfully brought key individuals togeth-
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er to discuss the criteria and primary stages
necessary for the eventual validation, regula-
tory acceptance, and implementation oftest
methods."
Workshop participants sought to iden-
tify more efficient ways for developers to
communicate information and gain accep-
tance of their new test methods by scien-
tists in various regulatory agencies without
having to systematically approach each
agency. For instance, a test method to
characterize the acute toxicity ofa chemical
to be used commercially might be ofinter-
est to the EPA, the Consumer Product
Safety Commission, the DOT, and
OSHA. On the other hand, a new test
method for a drug may be important to
the FDA, but of no interest to any other
agency. A question posed at the meeting
was how communications between stake-
holders might be streamlined to facilitate
the review and acceptance process.
Participants at the workshop breakout
session on future directions proposed the
creation of a clearinghouse through which
a developer could bring a new test method
to the attention of the appropriate federal
regulatory agency or agencies. The clear-
inghouse was envisioned as an interagency
coordinating committee that would facili-
tate communication between test method
developers and agency scientists regarding
new alternative test methods for various
endpoints. However, at what point in the
development and validation process should
communications be made with the clear-
inghouse? After a method has been devel-
oped and a validation study designed, con-
sultation with the clearinghouse might
determine that the design will not generate
sufficient data to be adequately evaluated
by regulatory agencies. However, if the
data are not communicated until after vali-
dation-an expensive procedure-there
are inadequate data to evaluate the useful-
ness ofthe method by the intended regula-
tory agencies, and much time and money
may have been wasted. The breakout
group conduded that a process was needed
to facilitate communications among all
stakeholders at all stages of development,
validation, and acceptance. Oliver Flint, a
principal scientist at Bristol-Myers Squibb
and executive secretary ofthe breakout ses-
sion, supports the idea of a clearinghouse.
Said Flint, "From the scientist's point of
view, this will have the advantage that
individual tests will not have to be revali-
dated for each regulatory agency; and from
the public's point ofview, that one agency
will not have lower or eccentrically differ-
ent standards from those ofanother."
The breakout panel suggested interpos-
ing a stage called prevalidation between the
stages of development and validation.
Prevalidation would generate enough data
for clearinghouse scientists to assess the
likelihood that the test method would pass
regulatory testing purposes. A negative
finding would stop the process. A positive
finding would justify the allocation of
additional time and funds for validation,
peer review, and hopefully, implementa-
tion. The clearinghouse might even assist
in identifying potential funding sources.
As discussed by the breakout group,
the clearinghouse would communicate
information about test methods, not prod-
ucts, and would have only an advisory
function to the participating agencies. Its
membership would include scientists from
all of the relevant federal agencies. Several
questions remained, however, such as
whether the clearinghouse would be a
revamped ICCVAM or a new interagency
coordinating committee, how the clearing-
house would be funded, and whether it
would eventually be set up to communi-
cate information efficiently to foreign and
international regulatory bodies.
ICCVAM co-chairperson William
Stokes, associate director ofAnimal and
Alternative Resources at the NIEHS,
agrees with the concepts of the clearing-
house and prevalidation and thinks it
would be useful. "Fifteen agencies have
worked well together in the ICCVAM to
develop the draft report so the proposed
clearinghouse functions could be the logi-
cal next step. It could have representatives
from each [ICCVAM member] agency and
'go international' down the road. Proposals
for enhanced international coordination at
all stages of validation and acceptance are
more likely to emerge at the OECD work-
shop, where the ICCVAM draft report and
workshop report will serve as working doc-
uments. The aim is to harmonize our
report with that of an OECD guidance
document to be developed in Stockholm."
Some workshop participants would like
to see animal tests phased out entirely and
as soon as possible. For instance, Michael
Balls, director of the European Center for
the Validation ofAlternative Methods, of
the European Union Joint Research
Center's Environment Institute, called for
greater efforts to find replacements for all
animal tests as soon as possible.
Many scientists at the meeting ex-
EHPnet Reliance on petroleum comes with a price. Because ofspills, such as the Evxon Valdz,
and the numerous barrels ofoil that leak from petroleum pipelines, deaning up petro-
leum-polluted water and soil is big business. The most common mechanical remedia-
tion techniques involve drumming, transportation, and remote disposal ofcontaminat-
edsoil andwater to special dump sites and treatment plants.
Recendy, an alternative tech-
nique called bioremediation has
been developed. Bioremediation
is the process of using a mix of
living microorganisms, nutrients,
and biological catalysts to rapidly
;~
ea
break down hydrocarbons in soil or water into nonhazardous, nonregulated, organic
fertilizer-like compounds. Bioremediation methods are estimated to be five to ten
times less expensive than mechanical methods ofremediation.
AWorld Vide Web site dedicated to bioremediation is located at URL: http://tig-
ger.jvnc.net/.-levins/microbes.html#top. This site was created by Oettco Products
Corporation, a company specializing in petroleum-oxidizing products. The site pro-
vides an overall explanation ofbioremediation methods, materials, and techniques that
have been used by professional bioremediation contractors over the last fifteen years.
The topics oudined indude basic concepts, typical commercial bioremediation materi-
als, the bioremediation industry, safety issues, soil remediation topics, eliminating
absorbed petroleum, deaningcoastal soil, andoil slicks on openwater.
Bioremediation is not only used to dean up petroleum spills, but is also used to
support basic sanitation infirastructures. Algae have been used to treat waste water for
over a century, but only recently have certain algae species been actively cultivated to
'digest waste." These methods are costeffectiveand produce littlewaste, as the leftover
algae can be dried and used as fertilizer. Bioremediation methodology and techniques
mayprovide a more environmentallysoundwayto helpdean up the environment.
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pressed the view that totally eliminating
the use of animals in testing appears
unlikely for the foreseeable future. Stokes
explained that despite some limitations of
current animal models used for testing,
they remain useful and necessary for the
protection of human health. "The degree
of relevance of information [to humans]
depends on the specific animal model
used, our understanding ofthe model, and
toxicity endpoint studied," he pointed out.
Balls, however, believes that animal testing
can be entirely replaced in the future.
"When I'm optimistic, I think it can be
done in 25 years. When I feel pessimistic, I
think in terms of50 years."
Although a specific deadline for replac-
ing animal models was not an outcome of
the meeting, George Lucier, director ofthe
Environmental Toxicology Program at the
NIEHS, believes the meeting was a signifi-
cant step in the right direction for several
reasons. "This meeting produced a signifi-
cant broadening ofthe definition of alter-
native models to include such things as
mechanistic data and mathematical mod-
els," he said. "And most importandy, all of
the stakeholders bought into the ideas put
forth for improving, especially streamlin-
ing, the approaches by
which we determine
human toxicity."
Great Lakes on
the Mend
The Great Lakes are on the
mend, according to recent
reports on the overall health of
the world's largest body of fresh
water. Yet persistent toxic com-
pounds continue to be dumped into the
lakes, and PCBs, DDT, and other chemi-
cals can stil be detected in lake sediments
and fish, causing potential health problems
for people who eat the fish. New health
studies indicate that pollution ofthe Great
Lakes could be contributing to subtle
health concerns in the region induding a
reduction in human sperm counts, higher
rates of breast cancer, low birth-weight
babies, andlearning disabilities in children.
The U.S. EPA and Environment
Canada concluded that water quality and
human health are improving in the Great
Lakes region, but the results are mixed.
The agencies presented these findings in
the State ofthe GreatLakes 1995, a bienni-
al report released inSeptember.
"I think it's safe to say this: there's no
doubt that contaminants are declining,"
says Harold Humphrey, veteran research
scientist for the Michigan Department of
Public Health. "Things are a bit berter. But
the question remains, what is going to hap-
pen with all of these subde health effects?
No one can answer that question yet."
The Great Lakes have been a receptacle
for awide variety ofpollutants for decades,
induding DDT, PCBs, pesticides, dioxin,
and more. It is a heavily industrialized
region: about one-fifth ofAmerican indus-
try and one-half of Canadian industry are
located along the Great Lakes or tributary
streams. Forty-two shoreline areas in the
Great Lakes, such as Indiana Harbor,
Milwaukee Harbor, and Green Bay
Harbor, have been designated as "areas of
concern"-the most degraded sites in the
basin-by the EPA and Environment
Canada. Thirty-five ofthe areas ofconcern
have public advisories against fish con-
sumption.
In view of the number of people con-
suming fish and the potential human
health impacts, the International Joint
Commission (IJC) Great Lakes Water
Quality Board called for a zero discharge of
persistent toxicants into the Great Lakes in
its seventh biennial report titled 1993-
-1995 Priorities and Progress Under the
Great Lakes Water Quality Agreement.
"Society must adopt a clear.and compre-
hensive action plan to vir-
tually eliminate persistent
toxic substances that are
threatening human health
and the future ofthe Great
Lakes ecosystem," the
report said. That goal has
yet to be achieved.
On the bright side, re-
_IW search detailed in the Siate ofthe
Great Lakes 1995 shows that levels of
DDT in women's breast milk (from
women living in a number of Canadian
cities in the Great Lakes area) have dedined
87% from more than 150 parts per million
in 1967 to 20 ppm in 1986. The levels of
PCBs in women's breast milk also has
declined. Results ofa Lake Michigan study
conducted by the Wisconsin Department
of Natural Resources show the amount of
PCBs in lake trout and salmon has
decreased by 80%.
In its report, the IJC advocates pollu-
tion prevention as an immediate step that
industry can take to help reduce persistent
toxicants in the Great Lakes. The water
quality board recommended that bina-
tional initiatives be adopted to build on
those gains, including new benchmarks,
management guidelines, and increased
monitoring.
John Westendorf, manager of water
quality and corporate environmental affairs
for Occidental Chemical Corporation in
Niagara Falls, New York, said his compa-
ny's Niagara Falls plant has reduced its air,
water, and hazardous waste discharges by
73% in the past five years.
"Industry is committed to doing a bet-
terjob as long as we're given some flexibili-
ty," Westendorfsays.
But Occidental opposes a zero-dis-
charge standard, Westendorfsays. At mini-
mum, chemicals are needed to control exot-
ic species such as the sea lamprey and zebra
mussel, he says. Sea lampreys prey on lake
trout and other game fish, and zebra mus-
sels clog water-intake pipes for utilities and
industries. Both exotic species have prolifer-
ated in the Great Lakes bythe millions.
Burkhard Mausberg, executive director
of Great Lakes United in Buffalo, New
York, says his organization supports zero
discharge and ecosystem management to
improve the Great Lakes. But he sees few
advances toward those goals in the politi-
callycharged policy arena.
Mausberg notes that the U.S. Congress
has pondered deep cuts in renewing the
Clean Water Act and EPA enforcement.
"What we're finding is the environmental
programs that are most progressive are
being cut. We don't need that right now,"
he says.
The Great Lakes Initiative, launched
by former President Bush and carried on
by President Clinton, envisions uniform
pollution-discharge standards for all the
Great Lakes states. It has been opposed by
most states thus far for economic reasons,
officials say.
While politics muddies the waters for
now, the IJC's Great Lakes Science
Advisory Board has called for more
research into the impacts of chemicals on
the reproductive, developmental, and
immune systems in animals and humans.
New research indicates that the discharge
of PCBs, pesticide residues, and dioxin
into the Great Lakes could be causing hor-
monal changes in some fish, birds, and
mammals.
The research is preliminary, according
to Theo Colborn of the World Wildlife
Fund, who is authoring a book on envi-
ronmental estrogens. But the effects on fish
could also materialize in humans, she says.
According to Humphrey, it's too early to
tell how substantial the risk is for humans.
"The concern among public health profes-
sionals is that we don't cry wolftoo much
so people believe us when the real wolf
comes along," he says.
East Meets Westfor Improved
Antimalarials
Malaria is one ofthe world's greatest pub-
lic health problems, striking 200-300 mi-
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